• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annsurgLink to Publisher's site
Ann Surg. May 1993; 217(5): 447–457.
PMCID: PMC1242819

Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial.

Abstract

OBJECTIVE: A prospective, randomized, double-blind study was completed comparing intraoperative chemical splanchnicectomy with 50% alcohol versus a placebo injection of saline in patients with histologically proven unresectable pancreatic cancer. METHODS: Standardized assessment of pain, mood, and disability due to pain was completed preoperatively and at 2-month intervals until death. Chemical splanchnicectomy with alcohol was performed in 65 patients, whereas 72 patients received the placebo. The two groups were similar with respect to age, sex, location, and stage of tumor, operation performed, the use of postoperative chemo- and radiation therapy, and initial assessment scores for pain, mood, and disability. RESULTS: No differences in hospital mortality or complications, return to oral intake, or length of hospital stay were observed. Mean pain scores were significantly lower in the alcohol group at 2-, 4-, and 6-month follow-up and at the final assessment (p < 0.05). To further determine the effect of chemical splanchnicectomy, patients were stratified into those with and without preoperative pain. In patients without preoperative pain, alcohol significantly reduced pain scores and delayed or prevented the subsequent onset of pain (p < 0.05). In patients with significant preoperative pain, alcohol significantly reduced existing pain (p < 0.05). Furthermore, patients with preexisting pain who received alcohol showed a significant improvement in survival when compared with controls (p < 0.0001). CONCLUSION: The results suggest that intraoperative chemical splanchnicectomy with alcohol significantly reduces or prevents pain in patients with unresectable pancreatic cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Potts JR, 3rd, Broughan TA, Hermann RE. Palliative operations for pancreatic carcinoma. Am J Surg. 1990 Jan;159(1):72–78. [PubMed]
  • de Rooij PD, Rogatko A, Brennan MF. Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg. 1991 Sep;78(9):1053–1058. [PubMed]
  • Proctor HJ, Mauro M. Biliary diversion for pancreatic carcinoma: matching the methods and the patient. Am J Surg. 1990 Jan;159(1):67–71. [PubMed]
  • Lillemoe KD, Sauter PK, Pitt HA, Yeo CJ, Cameron JL. Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet. 1993 Jan;176(1):1–10. [PubMed]
  • Bornman PC, Harries-Jones EP, Tobias R, Van Stiegmann G, Terblanche J. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet. 1986 Jan 11;1(8472):69–71. [PubMed]
  • Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988 Dec;75(12):1166–1168. [PubMed]
  • Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989 Aug;30(8):1132–1135. [PMC free article] [PubMed]
  • Copping J, Willix R, Kraft R. Palliative chemical splanchnicectomy. Arch Surg. 1969 Apr;98(4):418–420. [PubMed]
  • Flanigan DP, Kraft RO. Continuing experience with palliative chemical splanchnicectomy. Arch Surg. 1978 Apr;113(4):509–511. [PubMed]
  • Sharp KW, Stevens EJ. Improving palliation in pancreatic cancer: intraoperative celiac plexus block for pain relief. South Med J. 1991 Apr;84(4):469–471. [PubMed]
  • Gardner AM, Solomou G. Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy. Ann R Coll Surg Engl. 1984 Nov;66(6):409–411. [PMC free article] [PubMed]
  • Haslam JB, Cavanaugh PJ, Stroup SL. Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer. 1973 Dec;32(6):1341–1345. [PubMed]
  • Whittington R, Dobelbower RR, Mohiuddin M, Rosato FE, Weiss SM. Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients. Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1639–1644. [PubMed]
  • Lebovits AH, Lefkowitz M. Pain management of pancreatic carcinoma: a review. Pain. 1989 Jan;36(1):1–11. [PubMed]
  • Brown DL, Bulley CK, Quiel EL. Neurolytic celiac plexus block for pancreatic cancer pain. Anesth Analg. 1987 Sep;66(9):869–873. [PubMed]
  • Leung JW, Bowen-Wright M, Aveling W, Shorvon PJ, Cotton PB. Coeliac plexus block for pain in pancreatic cancer and chronic pancreatitis. Br J Surg. 1983 Dec;70(12):730–732. [PubMed]
  • Sharfman WH, Walsh TD. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain. 1990 Jun;41(3):267–271. [PubMed]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...